Table 3 Antimicrobial resistance profiles of FA-resistant ST5 and ST239 MRSA isolates
From: Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates
|  | ST5 MRSA isolates (n = 37) | ST239 MRSA isolates (n = 3) |
|---|---|---|
Ra(%) | R(%) | |
Tetracycline | 94.6 | 33.3 |
Gentamicin | 70.3 | 100 |
Penicillin | 100 | 100 |
Clindamycin | 100 | 100 |
Erythromycin | 100 | 100 |
Ciprofloxacin | 97.3 | 100 |
Linezolid | 0 | 0 |
Rifampicin | 5.4 | 100 |
Trimethoprim/sulfametho-xazole | 3.7 | 0 |
Nitrofurantoin | 0 | 0 |
Chloramphenicol | 5.4 | 0 |
Quinupristin/dalfopristin | 0 | 0 |
Vancomycin | 0 | 0 |